SNY
$47.71
Revenue | $14157Mn |
Net Profits | $2815Mn |
Net Profit Margins | 19.88% |
Sanofi’s revenue jumped 11.49% since last year same period to $14157Mn in the Q3 2024. On a quarterly growth basis, Sanofi has generated 24.4% jump in its revenue since last 3-months.
Sanofi’s net profit jumped 11.49% since last year same period to $2815Mn in the Q3 2024. On a quarterly growth basis, Sanofi has generated 152.92% jump in its net profits since last 3-months.
Sanofi’s net profit margin fell -0% since last year same period to 19.88% in the Q3 2024. On a quarterly growth basis, Sanofi has generated 103.31% jump in its net profit margins since last 3-months.
EPS Estimate Current Quarter | 1.38 |
EPS Estimate Current Year | 1.38 |
Sanofi’s earning per share (EPS) estimates for the current quarter stand at 1.38 - a 60.77% jump from last quarter’s estimates.
Sanofi’s earning per share (EPS) estimates for the current year stand at 1.38.
Earning Per Share (EPS) | 1.57 |
Sanofi’s earning per share (EPS) fell -43.32% since last year same period to 1.57 in the Q3 2024. This indicates that the Sanofi has generated -43.32% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2024-03-31 | 0.94 | 0.97 | 3.19% |
2024-06-30 | 0.86 | 0.93 | 8.14% |
2024-09-30 | 1.38 | 1.57 | 13.55% |